Precision Business Insights


Anti-inflammatory Drugs Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

The Anti-inflammatory Drugs Market: By Indication (Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Psoriatic Arthritis, Gout)By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Biologics, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)), By Formulation (Oral, Parenteral, Topical) By Distribution Channel (Hospital Pharmacy, Clinics, Online Pharmacy, Retail Pharmacy)By Geography


Anti-inflammatory Drugs Market


Market Outline: Anti-inflammatory Drugs Market

Anti-inflammatory alludes to the property of a substance or treatment that diminishes irritation or swelling. Anti-inflammatory drugs make up about the portion of analgesics, curing torment by decreasing aggravation instead of opioids, which influence the focal sensory system to square torment motioning to the brain. Anti-inflammatory drugs are utilized to treat joint inflammation, sprains, excruciating periods and other difficult conditions. The vast majority experience no difficulty taking these tablets. In any case, a few people create symptoms which can now and again be not kidding. Specifically – on the off chance that you have any cardiovascular (heart, stroke or vein) condition or certain gut conditions, or are elderly, these drugs are endorsed with alert and just where there are no choices and at the most minimal measurements and terms vital.


Market Dynamics: Anti-inflammatory Drugs Market 

The worldwide anti-inflammatory market has been driven by variables, for example, expanding the immune system and respiratory diseases, new medications in pipeline and expanding the adoption of anti-inflammatory drugs. The interest for anti-inflammatory drugs has been expanding inferable from the rise of anti-inflammatory biologics that are more focused on, viable and with lesser symptoms when contrasted with traditional medications. Additionally, expanding familiarity with anti-inflammatory market therapeutics and alluring government activities in the Asia-Pacific and LAMEA area are relied upon to drive the market amid the investigation time frame. Factors such as symptoms of anti-inflammatory medications and patent expiry issues of blockbuster drugs, (for example, Remicade), are known to hinder the market development.


Market Scope: Anti-inflammatory Drugs Market 

The Anti-inflammatory Drugs Market is classified on the basis of application, drug class, formulations, distribution channel, and geographical regions.

Based on application, the global Anti-inflammatory Drugs market is segmented into

  • Rheumatoid Arthritis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Multiple Sclerosis
  • Inflammatory Bowel Disease (IBD)
  • Psoriatic Arthritis
  • Gout

Based on Drug Class, the global Anti-inflammatory Drugs market is segmented into

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Biologics
  • Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)

Based on formulations, the global Anti-inflammatory Drugs market is segmented into

  • Oral
  • Parenteral
  • Topical

Based on End user, the global Anti-inflammatory Drugs market is segmented into

  • Hospital Pharmacy
  • Clinics
  • Online Pharmacy
  • Retail Pharmacy


 North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Market Summary: Anti-inflammatory Drugs Market 

The anti-inflammatory therapeutics market is described by the nearness of driving players. The players in the market are to a great extent concentrating on the advancement of biologicals, which have less reactions and better adequacy. In spite of the fact that biologics are costly, their improved wellbeing and adequacy will enable sellers to get a bigger offer of the market once launched. The ascend in key partnerships by merchants is one of the most recent patterns that will pick up footing in the anti-inflammatory therapeutics market in the coming years. The anti-inflammatory therapeutics market is right now an expansion in the procurement of anti-inflammatory therapeutics by significant merchants. For example, one of the main player Pfizer as of late obtained Anacor Pharmaceuticals. This helped Pfizer pick up the business rights for Anacor Pharmaceuticals’ crisaborole, a non-steroidal topical PDE-4 inhibitor with anti-inflammatory properties, which was endorsed by the US FDA.


Regional Analysis: Anti-inflammatory Drugs Market 

Geographically Anti-inflammatory Drugs Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America has risen as the main section of the worldwide anti-inflammatory therapeutics market. The presentation of cutting-edge anti-inflammatory therapeutics has supported more noteworthy acknowledgment of these medications by buyers in North America. With France, Italy, Germany, Spain, and the U.K. being the key patrons, the anti-inflammatory therapeutics market in Europe is additionally anticipated that would thrive. However, Asia Pacific is relied upon to develop as the quickest developing provincial market, driven by a huge patient pool, expanding dispensable wages, development in social insurance spending, and rising mindfulness about wellbeing. India and China house a few driving pharmaceutical organizations that are helping the extension of the market.


Market participants: Anti-inflammatory Drugs Market 

Some of the players in Anti-inflammatory Drugs Market

  • Allergan, Inc. (S.)
  • AbbVie Inc., (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Bayer AG (Switzerland)
  • Pfizer Inc. (US)
  • Reddys (India)
  • Novartis (Switzerland)
  • Sanofi Avemtis (France)
  • Eli Lilly (US)
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
Single User $ 4,400.00
Multiple User $ 6,600.00
Corporate User $ 8,900.00
buy now spinner

Our Clients